Increased iodide intake has been linked to the development of hypothyroidism and/or autoimmune thyroiditis in humans and animals, but the mechanisms involved remain poorly understood. Increased ingestion of iodide is likely to have pleiotropic effects on either metabolic or immunological processes. Within the latter domain, recent interest has been focused on two areas: a) the role of iodinated peptides in thyroglobulin (tg)-the molecular site of biosynthesis and storage of iodotyrosines and iodothyronines-in triggering an autoimmune cascade, and b) the role of iodine-induced apoptosis/necrosis of thyrocytes in the disease process. this review presents a brief summary of recent findings in these research areas.
A. INTRODUCTION
Epidemiological studies have linked increased iodide intake from dietary or other sources to the development of hypothyroidism, and it appears that in several-though not all-cases, this phenomenon has an autoimmune basis. 1 How does iodine trigger pathogenesis? Although work with animals prone to developing autoimmune thyroiditis after high iodide intake, such as Cornell strain (CS) chickens, 2 diabetesprone BioBreeding/Worcester (BB/W) and Buffalo rats, 3, 4 and non obese diabetic (NOD).H-2h4 mice, 5, 6 has provided valuable insights, an understanding of the events that initiate the autoimmune cascade is still lacking. The emerging picture indicates that the genetic background of the host plays a critical role at different levels, thus making it unlikely that a single mechanism of iodine-induced pathogenesis is responsible for experimental or human thyroiditis. The recommended daily allowance of iodine by the World Health Organization is 150 g for adults, 7 i.e. approximately 3x the amount (52 g) of iodine the gland must take up daily to remain in balance. 8 However, the average dietary iodide intake can often exceed this level, ranging from 5 mg per day in populations consuming seaweed 8, 9 to 500 g in the United States and Canada. 7, 10 Most persons tolerate chronic excess of iodide intakes of up to 600 g per day in the European Union, while 1100 g per day in the United States is declared as tolerable for adults. 8, 11 This has sparked debate as to whether iodide intakes of 300-400 g per day should be considered excessive or adequate. 12, 13 To compound the issue, the amount of iodine in individual foods and water can vary by a factor of 100, 14, 15 rendering quantitation of iodide intake extremely difficult. Thus, values of the median urinary excretion rate above 300 g I/l have been considered as indices of excessive iodide intake associated with increased risk of hypothyroidism. 13 Despite several studies (reviewed in 8,10), it remains unknown if and how iodide intake, at dietary levels close to the tolerable limits, influences development of autoimmune thyroiditis in euthyroid individuals over long time periods, and animal models of autoimmune thyroiditis have not yet addressed this issue. It appears likely, however, that due to genetic factors, general recommendations may not be equally applicable to various populations and different countries of the world. 13 Within an immunological context, iodine may mediate thyroiditis induction via at least two mechanisms: a) by increased post-translational modification of thyroglobulin (Tg), an event which may enhance the immunopathogenicity of this molecule as detailed further in this review; and b) via apoptotic/necrotic effects of thyrocytes, a step that could initiate presentation of thyroid antigens at immunostimulatory levels. This review summarizes recent findings related to these issues with emphasis on Tg immunogenicity, as this has been more extensively studied.
B. EFFECTS OF IODINE ON THE IMMUNOGENICITY OF Tg

B.1. Tg: a prohormone with strong pathogenic potential
Induction of experimental autoimmune thyroiditis (EAT) by challenging animals with Tg is well known since 1956 from the pioneering studies of Rose and Witebsky in rabbits. 16 In recent years, the view that the intrinsic pathogenicity of Tg merits detailed study at the molecular level has been strengthened mainly by two lines of research. First, linkage and association studies have highlighted Tg as the first thyroid-specific susceptibility gene in human autoimmune thyroid disease. [17] [18] [19] 20, 21 These peptides encompass mostly cryptic T-cell determinants, i.e. epitopes to which Tg-primed T cells do not respond in vitro and, conversely, peptide-primed T cells which are not activated by Tg in vitro. This "cryptic self" is not of minor importance since host genetics and environmental factors such as diet may promote both peptide generation over threshold levels and immunostimulatory conditions that can trigger autoreactive T cells. The mode by which iodine influences the formation of such epitopes is, therefore, an important step toward the understanding of pathogenesis.
B.2. Influences of iodine on the generation of pathogenic Tg T-cell determinants
Based on iodine involvement, pathogenic Tg peptides have been divided into three categories: a) peptides that contain hormonogenic sites, b) peptides that contain iodotyrosyl residues, and c) non-iodinated peptides.
B.2.1. Pathogenic Tg peptides containing hormonogenic sites
The 12mer Tg peptide (aa 2459-2560) containing thyroxine (T4) at aa position 2553, [T4(2553)], was the first T-cell determinant reported to induce EAT 22, 23 and subsequently it was found to elicit granulomatous EAT 24 and proliferative as well as cytotoxic T cell responses. 23, 25 Later, it was shown that the 12mer peptide (1-12) containing T4 at position 5, [T4 (5)],-the most active hormonogenic site of Tg, even at low iodine availability, 26, 27 induced weak EAT as well as T cell responses. 28 By contrast, the 12mer peptides containing T4 at positions 2567 and 2746 were devoid of immunopathogenicity. 28 Additional work with HLA-DRB1*0301 (DR3)-transgenic mice which carried no murine MHC class II antigens demonstrated that only T4(5) was mildly stimulatory for Tg-primed T cells, indicating that the T4-containing peptides are not dominant epitopes presented by DR3 molecules. 29 This was confirmed recently after sequencing DR3-bound peptides isolated from the thyroid tissue of a patient with Graves' disease. 30, 31 In CBA mice, the T4 (2553) determinant was classified as a subdominant epitope as it activated in vitro T cells, previously primed with either human or mouse Tg, for thyroiditis transfer. 28, 32 An analogue containing thyronine (T0) at position 2553, [T0(2553)], was also found to be immunogenic in CBA mice and it activated peptide-primed T cells for thyroiditis transfer, 28 suggesting that the presence of four iodine atoms within the T4 structure was not the only coefficient of immunogenicity. From a physiological standpoint, this is of limited importance as iodothyronine formation in vivo only occurs by the coupling of iodotyrosyl residues. Non-iodinated tyrosyl residues may be cross-linked to yield dityrosyl residues, which are unrelated to iodothyronines. 33 Interestingly, it was found that LNC from mice challenged with the T4(2553) peptide could not be crossstimulated in vitro with the T0(2553) analogue and this regimen failed to generate effector cells that could transfer EAT. These results suggested that the iodine atoms sufficiently modify the peptide-MHC complex to elicit distinct T cell clones that recognize only the iodinated determinant. This concept was subsequently confirmed with pathogenic Tg peptides containing iodotyrosyl residues (see below). Three main conclusions were drawn from this collective work: a) the presence of the two-phenyl-ring side chain of T4 within a Tg peptide is not sufficient to impart immunogenicity to that fragment; b) while the removal of the four iodine atoms from the T4(2553) peptide does not abrogate its immunogenicity, their presence might activate additional pathogenic clones that recognize only the iodine-modified peptide; and c) T4-containing peptides are not major Tg epitopes presented by DR3 molecules.
B.2.2. Pathogenic Tg peptides containing iodotyrosyl residues
We have previously reported that three tyrosinecontaining peptides, p117 (aa 117-132), p304 (aa 304-318), and p1931 (aa 1931-1945) , have been found to activate autoreactive T cells and cause EAT in CBA/J mice only in their iodinated (i.e. iodotyrosyl-containing) form, whereas the non-iodinated analogues are not immunogenic. 34 Peptide modification by the bulky iodine atom (atomic radius ~133 pm) seemed to facilitate either peptide binding to MHC or recognition of the neoantigenic determinant by distinct clones in the available T-cell receptor repertoire. Further work, however, showed that iodotyrosyl formation within other Tg peptides had variable effects on immune recognition as it enhanced (p179, aa 179-194), suppressed (p2540, aa 2540-2554) or did not alter (p2529, aa 2529-2545) their established immunogenicity. 35 Interestingly, such effects seemed not to influence the weak pathogenicity of these peptides. To investigate how a single iodine atom could affect recognition at the clonal T cell level, a panel of T-cell hybridoma clones were generated against the 16mer peptide p179 or its iodinated analogue I-p179. It was found that iodination of Y192 had unpredictable effects: some clones were activated only when the iodine atom was present, others when the iodine atom was lacking, and yet other clones were activated by both the p179 and I-p179 analogues, tolerating the presence of iodine. 36 This concept has also found support for B-cell epitopes via the use of monoclonal antibodies (mAbs). 37, 38 The implications of the above findings were two-fold. First, the results suggested that the identified iodinated peptides must be expressed intrathyroidally under steady-state conditions since adoptively transferred peptide-specific T cells mediated EAT. Second, it appears that formation of iodotyrosyl residues within a neoantigenic Tg determinant may have variable and unpredictable effects on Tg immunogenicity and pathogenicity as this event can turn either on or off the activation of individual effector T cell clones, depending on the particular site. The relative position of pathogenic Tg peptides containing iodine is shown schematically in Figure 1 .
B.2.3. Pathogenic Tg peptides lacking iodine
The delineation of several (at least 15) non-iodinated Tg peptides with pathogenic potential has been previously reviewed. 20, 21 The role, if any, of iodine in promoting the generation of these peptides can only be suggested indirectly from studies showing that the structure, 39 as well as the proteolytic degradation, 40, 41 of Tg is affected by its iodine content. This view is supported by our findings 42 demonstrating that processing of highly iodinated Tg in macrophages or dendritic cells leads to selective activation of a T-cell clone specific for the non-iodinated peptide (2495-2510). This response was not observed when Tg with a physiological iodine content was processed by the same antigen presenting cells (APC) and it was selective as it did not lead to activation of a T-cell clone directed cause suppression of T-cell autoreactivity directed to hormonogenic sites, in addition to any possible effects they may have on hypothyroidism due to T4 neutralization.
In vitro experiments have also shown that when APC process Tg bound to certain Tg-specific mAbs such as 5D2 and 3C4, this leads to activation of T4(2553)-specific T cells. 49 This effect was selective because it did not promote generation of other Tg peptides nor was it observed with other Tg-specific mAbs. It required the Fc receptor-mediated uptake of Tg as well as an intracellular processing step because it was abolished after APC treatment with chloroquine or glutaraldehyde. Although not formally shown, such a process may be facilitated in principle by Abs directed to iodotyrosyl-containing peptides such as the I-p117 localized on the surface of the Tg molecule. 34 These data suggested a mechanism whereby circulating anti-Tg Abs, frequently detectable even in euthyroid subjects, can precipitate T cell reactivity to iodinated pathogenic Tg determinants or help in the intramolecular "spreading" of the T cell response to cryptic Tg determinants during the later stages of disease.
B4. Is iodide-rich Tg (I-Tg) a critical link in autoimmune thyroiditis?
The unique capacity of Tg to store available ioagainst a different non-iodinated pathogenic peptide.
In another study, a hormonogenic carboxy-terminal fragment of Tg was released during enzymatic or metal-catalyzed oxidation of Tg in vitro. 43 Although these studies entailed supra-physiological levels of Tg iodination in vitro, they do suggest a mechanism whereby immune processing of Tg with increased iodine content might facilitate the "spreading" 44 of the immune response to non-iodinated but pathogenic Tg determinants. Other authors reported that the limited proteolysis in vitro of bovine and human Tg, physiologically iodinated in vivo, was not affected by the iodine content of the Tg preparation.
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B3. Regulation of Tg-specific T cell reactivity by antibodies (Abs) recognizing iodinated determinants
Abs binding to thyroid hormone are frequently found in patients with autoimmune thyroid disorders or animals developing EAT. 46, 47 We have previously shown that the 55H8 mAb, representing this subset, recognizes the 5΄ iodine atom of the outer phenolic ring of T4 within the T4(2553) peptide, even after the peptide is bound to the major histocompatibility complex (MHC) (A k ) groove. 48 Thus, 55H8 inhibits activation of T4(2553)-specific T cells and significantly reduces their capacity to transfer EAT to naive mice. This suggested that circulating T4-specific Abs may dine forces the immune system to cope with a self antigen that is continually and variably modified by an environmental element supplied in our diet. Numerous earlier EAT studies have attributed a critical role to Tg iodination in the disease process. In some studies, hypoiodinated Tg did not activate T cells, whereas by raising the Tg iodine content to normal levels in vitro, the pathogenicity and/or antigenicity of the molecule was re-established. [50] [51] [52] Toward the other end of the iodination spectrum, I-Tg was frequently, 42, 53, 54 but not always, 55 shown to possess increased immunopathogenic potential. The studies with defined Tg epitopes, described above, have provided a mechanistic framework to understand those earlier findings: iodine-mediated enhancement of Tg may be explained on a structural basis via formation of iodothyronines or iodotyrosyl residues within neoantigenic determinants or may occur indirectly via effects on Tg processing that generates non-iodinated pathogenic T cell epitopes. At the same time, new unanswered questions have emerged, one of them being why is non-iodinated Tg not pathogenic 51 given the large number of non-iodinated pathogenic peptides it contains. This appears even more paradoxical in view of the fact that iodine-free Tg was reported to be comparable to normal Tg in eliciting autoantibodies, implying T helper cell activation. 51 Other findings have also shed doubt upon the concept that I-Tg constitutes a critical link in the pathogenetic process of autoimmune thyroiditis. For example, I-Tg may cause EAT with increased incidence and severity in SJL mice, 42 but when these mice were fed a high iodide diet by drinking water with 0.05% NaI for 10 weeks, their Tg did not show high iodine content ex vivo and the mice developed goitrous hypothyroidism with only focal mononuclear cell infiltrates and no autoreactive responses to Tg. 56 These symptoms were reversed upon NaI withdrawal. The influence of polymorphic genes was suspected by the fact that the symptoms were not observed in CBA/J mice placed on a similar diet. Interestingly, a significant reduction of sodium/iodide symporter (NIS) mRNA was observed in CBA/J but not in SJL thyrocytes following NaI administration, allowing continuous iodide transport into the cells and possible failure to escape from the acute Wolff-Chaikoff effect. 56 We have suggested that the iodide-induced goitrous hypothyroidism of SJL mice constitutes a model of the non-autoimmune hypothyroidism observed among subjects in several parts of the world where large quantities of iodide are consumed. 1 Recent studies have made use of NOD.H-2h4 mice, a model of spontaneous autoimmune thyroiditis (SAT). Addition of NaI to the drinking water in these animals accelerates the onset of SAT from 7-10 months in the control mice to 2 months and significantly increases both its incidence and severity. 5, 6 However, the genetic background of this strain does not promote generation of I-Tg in vivo, and there is no evidence for differential B-cell or T-cell responses to Tg vs I-Tg in iodide-fed NOD.H-2h4 mice developing accelerated SAT. 57 Indeed, in vivo formation of I-Tg in normal (i.e. non-goitrous) mice exposed to a chronic iodide-rich diet has not yet been reported. These findings contrast with the view of Barin et al. that iodine accelerates thyroiditis in NOD.H-2h4 mice by directly enhancing the antigenicity of Tg. 50 Also, our data are not in agreement with earlier observations in obese strain (OS) chickens in which I-Tg formation is clearly observed during iodide-accelerated SAT. 54 The reasons behind this discrepancy remain unknown. Equally controversial remains the role of Tg iodination in the pathogenesis of human thyroiditis: iodine has been suggested as playing an essential role in the recognition of human Tg by T cells, 58 but other studies have reported that human T cells respond equally well to Tg preparations of varied iodine content. 59 In any event, the cumulative experimental evidence does seem to suggest that enhanced iodination of Tg is not a sine qua non in iodine-induced thyroiditis and other genetic or epigenetic factors may be at play.
C. INJURY OR APOPTOSIS OF THYROCYTES BY IODINE
High doses of iodide have been known to cause direct thyroid cell injury in several animal species [60] [61] [62] [63] [64] [65] or human thyroid follicles in vitro. 66 The resulting inflammatory trigger may initiate an autoreactive cascade in animals 60, 67 or humans with pre-existing goiters. [68] [69] [70] [71] However, events that occur when iodide is administered to iodopenic hosts may not necessarily reflect intrathyroidal changes occurring in euthyroid individuals on an iodide-rich diet (>500 g I/day). In this regard, work by Burek's laboratory has shown that the constitutive expression of the intracellular adhesion molecule-1 (ICAM-1) on thyrocytes of NOD.H2h4 mice is upregulated by iodine supplementation of drinking water, 72, 73 with concomitant increase in E-selectin and VCAM-1 expression on intrathyroidal endothelial cells. 72 These events may promote the homing of autoreactive lymphocytes in the thyroid gland. The same group has presented evidence suggesting that NOD.H-2h4 thyrocytes, but not thyrocytes from other mouse strains not prone to thyroiditis, are characterized by a high constitutive expression of NADPH oxidase. This characteristic facilitates a spike in the generation of reactive oxygen species (ROS) upon iodine uptake, leading to upregulation of ICAM-1 expression. 74, 75 The implications are that anti-oxidants may have therapeutic value in preventing autoimmune thyroiditis, this being in agreement with earlier findings of Bagchi et al, who showed that antioxidants delay the onset of thyroiditis in OS chickens. 76 Selenium has also been shown to prevent oxidative damage. 77 The iodide-induced generation of extracellular H2O2 by thyrocytes 75 may accelerate tissue damage via apoptotic/necrotic effects and the release of degraded thyroglobulin. 78 Ultrastructural changes in thyrocytes of NOD.H-2h4 mice on an iodide-rich diet have been reported to occur in a dosedependent manner and include an increased number of lysosomes, swollen mitochondria, condensation of nuclear chromatin, and destruction of the epithelial cell membrane.
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D. CONCLUSIONS
High dietary iodide intake may lead to the development of thyroid autoimmunity via at least two pathways. First, iodide may epigenetically modify the Tg molecule and create iodinated neoantigenic determinants to which immune tolerance has not been established or alter the processing of Tg to facilitate generation of pathogenic but cryptic Tg determinants that may not contain iodine. Second, iodine may precipitate apoptotic/necrotic effects on thyrocytes, thus releasing increased amounts of thyroid antigens that can activate autoreactive T cells in situ or in thyroid-draining lymph nodes. The genetic background of the host may be permissive to one or both of these pathways that may act in synergy or independently of each other. The use of NOD.H-2h4 mice chronically exposed to iodide levels as a model of our dietary habits may allow the study of early pathogenetic events of thyroid autoimmunity.
